The combined extract of purple waxy corn and ginger prevents cataractogenesis and retinopathy in streptozotocin-diabetic rats

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Thiraphatthanavong, Paphaphat ^a,b   Wattanathorn, Jintanaporn ^a,b   Muchimapura, Supaporn ^a,b   Thukham Mee, Wipawee ^a,b   Lertrat, Kamol ^b   Suriharn, Bhalang ^b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EYE PROTECTION; FOOD ADDITIVES; NEURONS; OPACITY;

ALDOSE REDUCTASE; BIOCHEMICAL ASSAY; BLOOD GLUCOSE LEVEL; CLINICAL TRIAL; DIABETIC CATARACT; GPX ACTIVITIES; PROTECTIVE EFFECTS; SYNERGISTIC EFFECT;

RATS;

ALDEHYDE REDUCTASE; ANTIOXIDANT; CATALASE; GINGER EXTRACT; GLUCOSE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; PLANT EXTRACT; PURPLE WAXY CORN EXTRACT; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICATARACT EFFECT; ANTIOXIDANT ACTIVITY; ARTICLE; CATARACT; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE SEVERITY; DRUG ACTIVITY; ENZYME ACTIVITY; GINGER; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; LENS CAPSULE; LENS FIBER; MAIZE; MALE; NERVE CELL; NONHUMAN; OXIDATIVE STRESS; RAT; RETINA; RETINAL THICKNESS; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TREATMENT DURATION; ANIMAL; BLOOD; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; METABOLISM; PATHOLOGY; WISTAR RAT;

RATTUS; ZEA MAYS; ZINGIBER OFFICINALE;

ANIMALS; BLOOD GLUCOSE; CATARACT; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; GINGER; MALE; PLANT EXTRACTS; RATS; RATS, WISTAR; STREPTOZOCIN; ZEA MAYS;

EID: 84921300715     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/789406     Document Type: Article

References (34)

1. R. L. Engerman and T. S. Kern, "Hyperglycemia as a cause of diabetic retinopathy," Metabolism, vol. 35, supplement 1, no. 4, pp. 20-23, 1986.
2. A. Pollreisz and U. Schmidt-Erfurth, "Diabetic cataract- pathogenesis, epidemiology and treatment," Journal of Ophthalmology, vol. 2010,Article ID 608751, 8 pages, 2010.
3. I. G. Obrosova, S. S. M. Chung, and P. F. Kador, "Diabetic cataracts: mechanisms and management," Diabetes/Metabolism Research and Reviews, vol. 26, no. 3, pp. 172-180, 2010.
4. J. Ding and T. Y. Wong, "Current epidemiology of diabetic retinopathy and diabetic macular edema," Current Diabetes Reports, vol. 12, no. 4, pp. 346-354, 2012.
5. A. Y. W. Lee and S. S. M. Chung, "Contributions of polyol pathway to oxidative stress in diabetic cataract," The FASEB Journal, vol. 13, no. 1, pp. 23-30, 1999.
6. S. A. Madsen-Bouterse and R. A. Kowluru, "Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives," Reviews in Endocrine and Metabolic Disorders, vol. 9, no. 4, pp. 315-327, 2008.
7. I. G. Obrosova and P. F. Kador, "Aldose reductase/polyol inhibitors for diabetic retinopathy," Current Pharmaceutical Biotechnology, vol. 12, no. 3, pp. 1389-2010, 2011.
8. V. R. Drel, P. Pacher, T. K. Ali et al., "Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis," International Journal of Molecular Medicine, vol. 21, no. 6, pp. 667-676, 2008.
9. P. Thiraphatthanavong, J. Wattanathorn, S. Muchimapura et al., "Preventive effect of Zea mays L. (Purple Waxy Corn) on experimental diabetic cataract," BioMed Research International, vol. 2014, Article ID 507435, 8 pages, 2014.
10. Y. Morimitsu, K. Kubota, T. Tashiro, E. Hashizume, T. Kamiya, and T. Osawa, "Inhibitory effect of anthocyanins and colored rice ondiabetic cataract formation in the rat lenses," International Congress Series, vol. 1245, pp. 503-508, 2002.
11. M. Saraswat, P. Suryanarayana, P. Y. Reddy, M. A. Patil, N. Balakrishna, and G. B. Reddy, "Antiglycating potential of Zingiber officinalis and delay of diabetic cataract in rats,"Molecular Vision, vol. 16, pp. 1525-1537, 2010.
12. Y. Li, V. H. Tran, C. C. Duke, and B. D. Roufogalis, "Preventive and protective properties of Zingiber officinale (Ginger) in diabetes mellitus, diabetic complications, and associated lipid and other metabolic disorders: a brief review," Evidence-based Complementary and Alternative Medicine, vol. 2012, Article ID 516870, 10 pages, 2012.
13. P. Suryanarayana, M. Saraswat, T. Mrudula, T. P. Krishna, K. Krishnaswamy, and G. B. Reddy, "Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats," Investigative Ophthalmology & Visual Science, vol. 46, no. 6, pp. 2092-2099, 2005.
14. H. Ohkawa, N. Ohishi, and K. Yagi, "Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction," Analytical Biochemistry, vol. 95, no. 2, pp. 351-358, 1979.
15. Y. Sun, L. W. Oberley, and Y. Li, "A simple method for clinical assay of superoxide dismutase," Clinical Chemistry, vol. 34, no. 3, pp. 497-500, 1988.
16. L. Góth, "A simple method for determination of serum catalase activity and revision of reference range," Clinica Chimica Acta, vol. 196, no. 2-3, pp. 143-151, 1991.
17. J. T. Rotruck, A. L. Pope, H. E. Ganther, A. B. Swanson, D. G. Hafeman, and W. G. Hoekstra, "Selenium: biochemical role as a component of glatathione peroxidase," Science, vol. 179, no. 4073, pp. 588-590, 1973.
18. M. B. Patel and S. M. Mishra, "Aldose reductase inhibitory activity and anti catraract potential of some traditionally acclaimed antidiabetic medicinal plants," Oriental Pharmacy and Experimental Medicine, vol. 9, no. 3, pp. 245-251, 2009.
19. R. Agarwal, I. Iezhitsa, N. A. Awaludin et al., "Effects of magnesium taurate on the onset and progression of galactoseinduced experimental cataract: in vivo and in vitro evaluation," Experimental Eye Research, vol. 110, pp. 35-43, 2013.
20. P. M. Martin, P. Roon, T. K. van Ells, V. Ganapathy, and S. B. Smith, "Death of retinal neurons in streptozotocin-induced diabetic mice," Investigative Ophthalmology and Visual Science, vol. 45, no. 9, pp. 3330-3336, 2004.
21. H. W. van Dijk, F. D. Verbraak, P. H. B. Kok et al., "Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes," Investigative Ophthalmology and Visual Science, vol. 51, no. 7, pp. 3660-3665, 2010.
22. T. S. Kern and A. J. Barber, "Retinal ganglion cells in diabetes," Journal of Physiology, vol. 586, no. 18, pp. 4401-4408, 2008.
23. G. A. Ramadan, "Sorbitol-induced diabetic-like retinal lesions in rats: microscopic study," American Journal of Pharmacology and Toxicology, vol. 2, no. 2, pp. 89-97, 2007.
24. B. Özmen, D. Özmen, E. Erkin, I. Güner, S. Habif, and O. Baymdir, "Lens superoxide dismutase and catalase activities in diabetic cataract," Clinical Biochemistry, vol. 35,no. 1, pp. 69-72, 2002.
25. A. B. M. Reddy, R. Tammali, R. Mishra, S. Srivastava, S. K. Srivastava, and K. V. Ramana, "Aldose reductase deficiency protects sugar-induced lens opacification in rats," Chemico-Biological Interactions, vol. 191, no. 1-3, pp. 346-350, 2011.
26. P. Thiraphatthanavong, J. Wattanathorn, S. Muchimapura et al., "Preventive effect of Zea mays L. (purple waxy corn) on experimental diabetic cataract," BioMed Research International, vol. 2014, Article ID 507435, 8 pages, 2014.
27. I. G. Obrosova and P. F. Kador, "Aldosereductase/polyol inhibitors for diabetic retinopathy," Current Pharmaceutical Biotechnology, vol. 12, no. 3, pp. 373-385, 2011.
28. P. Maher and A. Hanneken, "Flavonoids protect retinal ganglion cells from oxidative stress-induced death," Investigative Ophthalmology and Visual Science, vol. 46, no. 12, pp. 4796-4803, 2005.
29. M. Stefek, "Natural flavonoids as potential multifunctional agents in prevention of diabetic cataract," Interdisciplinary Toxicology, vol. 4, no. 2, pp. 69-77, 2011.
30. S. F. Nabavi, S. Habtemariam, M. Daglia, N. Shafighi, A. J. Barber, and S. M. Nabavi, "Anthocyanins as a potential therapy for diabetic retinopathy," Current Medicinal Chemistry, vol. 22, no. 1, pp. 51-58, 2014.
31. A. H. Rahmani, F. M. Al Shabrmi, and S. M. Aly, "Active ingredients of ginger as potential candidates in the prevention and treatment of diseases via modulation of biological activities," International Journal of Physiology, Pathophysiology and Pharmacology, vol. 6, no. 2, pp. 125-136, 2014.
32. H. Watanabe, H. Kosano, and H. Nishigori, "Steroid-induced short termdiabetes in chick embryo: reversible effects of insulin on metabolic changes and cataract formation," Investigative Ophthalmology & Visual Science, vol. 41, no. 7, pp. 1846-1852, 2000.
33. E. R. James, "The etiology of steroid cataract," Journal of Ocular Pharmacology and Therapeutics, vol. 23, no. 5, pp. 403-420, 2007.
34. P. Greaves, Histopathological of Preclinical Toxicity Studies, Elsevier, New York, NY, USA, 3rd edition, 2007.